FDA Approved: PAZOPANIB — Original Application (Novugen Pharma (USA) LLC.)

View source ↗

Summary

FDA approved pazopanib hydrochloride as an original ANDA, enabling a generic version of pazopanib.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma
• Soft Tissue Sarcoma

Drugs mentioned

• Pazopanib hydrochloride (pazopanib)

Snippet

ORIG AP for PAZOPANIB (PAZOPANIB HYDROCHLORIDE)